<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=1200, user-scalable=yes, initial-scale=0.4, minimum-scale=0.1">
    <title>BZP - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
        
        // Force desktop behavior by overriding mobile detection
        window.isMobile = false;
        window.isDesktop = true;
        
        // Override any mobile detection functions
        if (window.matchMedia) {
            const originalMatchMedia = window.matchMedia;
            window.matchMedia = function(query) {
                // Force desktop media queries to always match for min-width
                // and mobile queries to never match
                if (query.includes('max-width') && (query.includes('768px') || query.includes('480px'))) {
                    return { matches: false, addListener: function() {}, removeListener: function() {} };
                }
                if (query.includes('min-width')) {
                    return { matches: true, addListener: function() {}, removeListener: function() {} };
                }
                return originalMatchMedia.call(this, query);
            };
        }
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚ÜÅE<a href="/dyos-domain/stimulants/">Stimulants</a> ‚ÜÅE<span>BZP</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>‚ö° BZP</h1>
        <h2 class="chemical-name">N-Benzylpiperazine</h2>
         <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="BZP" 
                data-category="Stimulants" 
                data-chemical="N-Benzylpiperazine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>N-Benzylpiperazine</span> ‚Ä¢ <span>1-Benzylpiperazine</span> ‚Ä¢ <span>Benzylpiperazine</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Legal E</span> ‚Ä¢ <span>Legal X</span> ‚Ä¢ <span>Party Pills</span> ‚Ä¢ <span>Herbal Highs</span>
            </div>
            <div class="name-category">
              <h4>Brand Names (Historical)</h4>
              <span>Charge+</span> ‚Ä¢ <span>Fast Lane</span> ‚Ä¢ <span>Frenzy</span> ‚Ä¢ <span>Twisted</span>
            </div>
            <div class="name-category">
              <h4>Chemical Abbreviations</h4>
              <span>1-BP</span> ‚Ä¢ <span>BZP-HCl</span> ‚Ä¢ <span>N-BP</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category stimulant">Stimulant</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration long">6-8 hours</span>
          <span class="adulterant">Common adulterant</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/Dyo-s-Dubious-Domain/assets/substances/bzp.jpg" alt="BZP powder and pills" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇÅH‚ÇÅ‚ÇÜN‚ÇÅE/p>
            <p>MW: 176.26 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure BZP (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine crystals, sometimes clumpy</li>
            <li><strong>Odor:</strong> Faint amine-like smell, sometimes fishy</li>
            <li><strong>Taste:</strong> Intensely bitter, very unpleasant</li>
            <li><strong>Solubility:</strong> Readily soluble in water, alcohol</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Common Street Forms</h4>
          <ul>
            <li><strong>Pills/Tablets:</strong> Often colored, various shapes and logos</li>
            <li><strong>Capsules:</strong> Usually combined with TFMPP or caffeine</li>
            <li><strong>Powder:</strong> White to tan powder, often mixed with other substances</li>
            <li><strong>"Party Pills":</strong> Commercial preparations with herbs and stimulants</li>
          </ul>
        </div>
        
        <div class="combination-warning">
          <h4>‚ö†ÔøΩEÔøΩECommon Combinations & Adulterants</h4>
          <p><strong>Classic combo:</strong> BZP + TFMPP (attempts to mimic MDMA)</p>
          <p><strong>In fake MDMA:</strong> Combined with caffeine, phenylethylamines</p>
          <p><strong>Party pills:</strong> Mixed with caffeine, taurine, herbal extracts</p>
          <p><strong>Dangerous mixes:</strong> Sometimes found with 2C-B, mCPP, or amphetamines</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      
      <div class="adulterant-warning">
        <h4>‚ö†ÔøΩEÔøΩEAdulterant Context Warning</h4>
        <p>BZP is primarily encountered as an adulterant in fake MDMA pills rather than as a sought-after substance. These dosages are for educational purposes - BZP is generally considered an undesirable substitution with inferior effects and significant side effects.</p>
      </div>
      
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">25-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">50-75mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">75-150mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">150-200mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">200mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="combination-dosing">
        <h4>BZP + TFMPP Combination (common adulterant mix)</h4>
        <ul>
          <li><strong>Typical ratio:</strong> 3:1 BZP:TFMPP (e.g., 75mg BZP + 25mg TFMPP)</li>
          <li><strong>Total dose range:</strong> 100-200mg combined</li>
          <li><strong>Effects:</strong> Attempts to mimic MDMA but with more side effects</li>
        </ul>
      </div>
      
      <div class="dosage-details">
        <h4>Dosage Considerations</h4>
        <ul>
          <li><strong>Individual sensitivity:</strong> Varies significantly between users</li>
          <li><strong>Tolerance:</strong> Develops quickly with repeated use</li>
          <li><strong>Duration:</strong> Effects last 6-8 hours, longer than MDMA</li>
          <li><strong>Redosing:</strong> Not recommended due to increased side effects</li>
          <li><strong>Body weight:</strong> Heavier users may require higher doses</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> BZP is often found in pills sold as MDMA. Always test substances - BZP produces a distinct orange/red color with Marquis reagent.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-1:30</span>
          <span class="effect">Onset - energy increase, mild euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:30-4:00</span>
          <span class="effect">Peak - stimulation, mild empathogenic effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Plateau - continued stimulation with side effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-24:00</span>
          <span class="effect">Comedown - fatigue, possible depression</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÅEPositive Effects</h4>
          <ul>
            <li>Mild euphoria and mood lift</li>
            <li>Increased energy and alertness</li>
            <li>Enhanced sociability</li>
            <li>Mild empathogenic feelings</li>
            <li>Increased confidence</li>
            <li>Enhanced music appreciation</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùÅENegative Effects</h4>
          <ul>
            <li>Severe nausea and vomiting</li>
            <li>Intense headaches</li>
            <li>Jaw clenching and teeth grinding</li>
            <li>Jittery, anxious stimulation</li>
            <li>Insomnia and sleep disruption</li>
            <li>Unpleasant taste and dry mouth</li>
          </ul>
        </div>
      </div>

      <div class="unique-characteristics">
        <h4>üéØ Unique Characteristics</h4>
        <div class="characteristic-item">
          <h5>MDMA Impostor</h5>
          <p>BZP produces some superficially similar effects to MDMA but lacks the deep empathogenic and euphoric qualities. Users often report feeling "stimulated but not satisfied."</p>
        </div>
        <div class="characteristic-item">
          <h5>Side Effect Profile</h5>
          <p>Notable for producing more negative side effects than positive ones, including severe nausea, headaches, and an unpleasant "speedy" feeling without the positive mood effects of other stimulants.</p>
        </div>
        <div class="characteristic-item">
          <h5>Long Duration</h5>
          <p>Effects last significantly longer than MDMA (6-8 hours vs 4-6 hours), often leaving users feeling overstimulated and unable to sleep.</p>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>BZP acts primarily as a norepinephrine and dopamine releasing agent with some serotonin activity. Unlike MDMA, it has much weaker serotonin effects, explaining why it lacks the strong empathogenic and euphoric qualities. It binds to monoamine transporters and causes release of stored neurotransmitters, but with a different selectivity profile than MDMA.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>NET (NE transporter)</strong></span>
            <span class="affinity">High affinity (IC50: ~240 nM)</span>
            <span class="function">Primary stimulant effects, alertness, energy</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>DAT (DA transporter)</strong></span>
            <span class="affinity">Moderate affinity (IC50: ~1.2 ŒºM)</span>
            <span class="function">Mild euphoric effects, reward pathway</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>SERT (5-HT transporter)</strong></span>
            <span class="affinity">Weak affinity (IC50: ~6.5 ŒºM)</span>
            <span class="function">Limited empathogenic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2A receptor</strong></span>
            <span class="affinity">Very weak agonist</span>
            <span class="function">Minimal psychedelic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Œ±1-adrenergic receptor</strong></span>
            <span class="affinity">Moderate antagonist</span>
            <span class="function">May contribute to side effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary metabolism:</strong> Hepatic metabolism via CYP enzymes</p>
          <p><strong>Active metabolites:</strong> 4-OH-BZP and other hydroxylated metabolites</p>
          <p><strong>Half-life:</strong> 5-6 hours for BZP, longer for active metabolites</p>
          <p><strong>Excretion:</strong> Primarily urinary, both unchanged and as metabolites</p>
          <p><strong>Peak plasma:</strong> 1-2 hours after oral administration</p>
          <p><strong>Bioavailability:</strong> Good oral bioavailability (~80%)</p>
        </div>

        <h4>Comparison to MDMA</h4>
        <div class="mdma-comparison">
          <p><strong>Serotonin activity:</strong> Much weaker than MDMA - explains lack of empathy/euphoria</p>
          <p><strong>Dopamine activity:</strong> Similar to MDMA but without balancing serotonin effects</p>
          <p><strong>Norepinephrine:</strong> Stronger than MDMA - contributes to jittery, anxious stimulation</p>
          <p><strong>Duration:</strong> Longer than MDMA due to different metabolism</p>
          <p><strong>Side effects:</strong> More pronounced negative effects, less positive ones</p>
        </div>

        <h4>BZP + TFMPP Combination Pharmacology</h4>
        <ul>
          <li><strong>Synergistic effects:</strong> TFMPP adds serotonin activity to BZP's dopamine/norepinephrine effects</li>
          <li><strong>TFMPP mechanism:</strong> Primarily a 5-HT1A agonist and 5-HT2A/2C agonist</li>
          <li><strong>Combined profile:</strong> Attempts to recreate MDMA's multi-neurotransmitter activity</li>
          <li><strong>Side effect amplification:</strong> Both substances contribute to nausea and headaches</li>
          <li><strong>Still inferior:</strong> Combination still lacks MDMA's unique entactogenic profile</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†ÔøΩEÔøΩESafety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Cardiovascular stress:</strong> Can cause dangerous blood pressure increases</li>
            <li><strong>Seizure risk:</strong> Potential for seizures at high doses</li>
            <li><strong>Deceptive marketing:</strong> Often sold as "legal MDMA" with false safety claims</li>
            <li><strong>Adulterant risk:</strong> Usually encountered unexpectedly in fake MDMA</li>
            <li><strong>Combination dangers:</strong> Often mixed with other stimulants increasing risks</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°ÔøΩEÔøΩEEssential Precautions</h4>
          <ul>
            <li>Always test substances - BZP gives orange/red with Marquis reagent</li>
            <li>Avoid if you have heart conditions, high blood pressure, or anxiety disorders</li>
            <li>Stay hydrated but don't over-hydrate</li>
            <li>Use in safe environment with trusted people</li>
            <li>Don't combine with other stimulants or depressants</li>
            <li>Have anti-nausea medication available</li>
          </ul>
        </div>
      </div>

      <div class="side-effect-management">
        <h4>ü§¢ Managing Common Side Effects</h4>
        <ul>
          <li><strong>Nausea:</strong> Ginger, small amounts of food, anti-emetics if available</li>
          <li><strong>Headaches:</strong> Hydration, electrolytes, avoid additional stimulants</li>
          <li><strong>Jaw clenching:</strong> Magnesium supplements, chewing gum</li>
          <li><strong>Insomnia:</strong> Avoid late dosing, consider melatonin for sleep</li>
          <li><strong>Anxiety:</strong> Calm environment, breathing exercises, benzodiazepines if prescribed</li>
        </ul>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Heart conditions, high blood pressure, anxiety disorders, seizure disorders, or are taking MAOIs, SSRIs, or other psychiatric medications. BZP is particularly problematic for those with cardiovascular issues.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏ÅEDrug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Risk of hypertensive crisis and serotonin syndrome</li>
            <li><strong>Other stimulants:</strong> Increased cardiovascular strain and seizure risk</li>
            <li><strong>SSRIs/SNRIs:</strong> Potential serotonin syndrome, altered effects</li>
            <li><strong>Tramadol:</strong> Increased seizure risk</li>
            <li><strong>DXM:</strong> Risk of serotonin syndrome</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Risky</h4>
          <ul>
            <li><strong>Alcohol:</strong> Increased dehydration and cardiovascular stress</li>
            <li><strong>Cannabis:</strong> May increase anxiety and paranoia</li>
            <li><strong>Caffeine:</strong> Amplifies jittery effects and anxiety</li>
            <li><strong>Psychedelics:</strong> Unpredictable interactions</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>TFMPP:</strong> Common combination but increases side effects</li>
            <li><strong>Phenylethylamines:</strong> Risk of overstimulation</li>
            <li><strong>Energy drinks:</strong> Additional stimulant load</li>
          </ul>
        </div>
      </div>

      <div class="interaction-note">
        <h4>‚ö†ÔøΩEÔøΩEAdulterant Interaction Risk</h4>
        <p>Since BZP is often encountered unexpectedly in pills sold as other substances, users may unknowingly combine it with other drugs they're taking, creating dangerous interactions. Always test substances to avoid unexpected BZP exposure.</p>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏ÅELegal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United States</h4>
            <p><strong>Schedule I</strong> - Controlled substance since 2004. Illegal to manufacture, possess, or distribute.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United Kingdom</h4>
            <p><strong>Class C</strong> - Controlled under the Misuse of Drugs Act since 2009.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE New Zealand</h4>
            <p><strong>Class C</strong> - Previously legal as "party pills" until banned in 2008.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE Australia</h4>
            <p><strong>Schedule 9</strong> - Prohibited substance in most states.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE European Union</h4>
            <p><strong>Controlled</strong> - Banned in most EU countries following risk assessments.</p>
          </div>
        </div>
        
        <div class="legal-history">
          <h4>üìú Legal Timeline</h4>
          <p>BZP was initially uncontrolled and marketed as a "legal high" alternative to MDMA. However, mounting evidence of health risks and widespread abuse led most countries to ban it between 2004-2010. New Zealand had a particularly notable "party pill" industry before banning BZP.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1940s</span>
          <p>BZP first synthesized for pharmaceutical research as a potential antidepressant</p>
        </div>
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Investigated as veterinary antihelminthic (anti-worm) drug</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Emerges in New Zealand as "legal party pill" ingredient</p>
        </div>
        <div class="history-event">
          <span class="year">2000s</span>
          <p>Widespread use as MDMA adulterant and "legal high" worldwide</p>
        </div>
        <div class="history-event">
          <span class="year">2004</span>
          <p>United States schedules BZP as controlled substance</p>
        </div>
        <div class="history-event">
          <span class="year">2008</span>
          <p>New Zealand bans BZP, ending major "party pill" industry</p>
        </div>
        <div class="history-event">
          <span class="year">2009</span>
          <p>European Union recommends control measures for BZP</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>"Legal High" Era</h4>
        <p>BZP became synonymous with the early 2000s "legal high" movement, particularly in New Zealand where it was sold in colorful packages as "party pills." Marketing targeted young adults seeking MDMA-like effects without legal consequences, but the reality was a substance with inferior effects and significant side effects.</p>
        
        <h4>MDMA Adulterant Legacy</h4>
        <p>BZP's most lasting impact has been as a common adulterant in fake MDMA pills. This deceptive use has caused countless disappointing and unpleasant experiences for users expecting MDMA's empathogenic effects but instead receiving BZP's inferior stimulation and harsh side effects.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Toxicology Studies</h4>
          <p>Research focuses on understanding BZP's cardiovascular and neurological risks, particularly in combination with TFMPP and other common adulterants.</p>
        </div>
        
        <div class="research-item">
          <h4>Forensic Detection</h4>
          <p>Development of analytical methods to detect BZP in seized drugs and biological samples, important for law enforcement and medical treatment.</p>
        </div>
        
        <div class="research-item">
          <h4>Pharmacokinetic Studies</h4>
          <p>Research into BZP metabolism and elimination to better understand its duration and potential for accumulation with repeated use.</p>
        </div>
        
        <div class="research-item">
          <h4>Adulterant Pattern Analysis</h4>
          <p>Studies tracking BZP's use as an adulterant in illicit drug markets to inform harm reduction and testing strategies.</p>
        </div>
      </div>

      <div class="research-limitations">
        <h4>Research Challenges</h4>
        <p>Limited therapeutic interest in BZP means most research focuses on toxicology and forensic applications rather than potential benefits. The substance's primary relevance is as a public health concern due to its deceptive marketing and adulterant use.</p>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Testing & Identification</h4>
        <ul>
          <li><a href="https://drugsdata.org/">DrugsData.org</a> - Lab testing service</li>
          <li><a href="https://bunkpolice.com/">The Bunk Police</a> - Reagent test kits</li>
          <li><a href="https://dancesafe.org/">DanceSafe</a> - Harm reduction and testing</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Educational Resources</h4>
        <ul>
          <li><a href="https://erowid.org/chemicals/bzp/">Erowid BZP Vault</a> - Experience reports and information</li>
          <li><a href="https://psychonautwiki.org/wiki/BZP">PsychonautWiki</a> - Comprehensive drug information</li>
          <li><a href="https://bluelight.org/">Bluelight</a> - Harm reduction forum</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Medical & Safety</h4>
        <ul>
          <li><a href="https://tripsit.me/">TripSit</a> - Crisis support and information</li>
          <li><a href="https://rollsafe.org/">RollSafe</a> - MDMA harm reduction (for comparison)</li>
          <li><a href="https://www.emcdda.europa.eu/">EMCDDA</a> - European drug monitoring</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="medical-disclaimer">
    <h3>‚öïÔ∏ÅEMedical Disclaimer</h3>
    <p><strong>This information is for educational purposes only and is not medical advice.</strong> BZP carries significant health risks and is primarily encountered as an unwanted adulterant. The information presented here does not constitute an endorsement or recommendation for use. Anyone who suspects they have consumed BZP should seek appropriate medical attention if adverse effects occur.</p>
  </div>

</div>


    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
    
    <!-- Only load interaction-checker.js on interaction checker page -->
    
</body>
</html>